Weihong Jin

Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.

Shuxia Zhao, Leigh Zawel, Stephen Fawell, 2013, Cancer discovery.

Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinase.

J. English, P. Kirschmeier, W. Windsor, 2014, Journal of medicinal chemistry.

NEK7 promotes gastric cancer progression as a cell proliferation regulator

Xiaoran Zhu, Weihong Jin, W. Yuan, 2021, Cancer cell international.

Expression and purification of phosphorylated and non-phosphorylated human MEK1.

Catherine K. Smith, W. Windsor, T. Mayhood, 2007, Protein expression and purification.

Analysis of the ERK1,2 transcriptome in mammary epithelial cells.

F. Gheyas, Luquan Wang, Wei Ding, 2004, The Biochemical journal.

MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology.

K. Cox, P. Kirschmeier, R. Doll, 2018, ACS medicinal chemistry letters.